Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study
- 1 January 2013
- journal article
- research article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 110, S49-S56
- https://doi.org/10.1016/j.ymgme.2013.09.015
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The 48-hour tetrahydrobiopterin loading test in patients with phenylketonuria: Evaluation of protocol and influence of baseline phenylalanine concentrationMolecular Genetics and Metabolism, 2011
- Up to date knowledge on different treatment strategies for phenylketonuriaMolecular Genetics and Metabolism, 2011
- PhenylketonuriaThe Lancet, 2010
- Nutritional issues in treating phenylketonuriaJournal of Inherited Metabolic Disease, 2010
- Optimizing the use of sapropterin (BH4) in the management of phenylketonuriaMolecular Genetics and Metabolism, 2009
- The truth of treating patients with phenylketonuria after childhood: The need for a new guidelineJournal of Inherited Metabolic Disease, 2008
- Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH4) in phenylketonuria and its use in treatmentMolecular Genetics and Metabolism, 2007
- Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled studyThe Lancet, 2007
- How practical are recommendations for dietary control in phenylketonuria?The Lancet, 2002
- Diet and compliance in phenylketonuriaEuropean Journal of Pediatrics, 2000